Efficacy and Complications of Interarytenoid Injection for Dysphagia in Infants 1‐Year‐Old and Under

Abstract

ObjectiveThe objective of this study was to assess the efficacy and complication rates of interarytenoid injection augmentation (IAIA) for the treatment of dysphagia in patients 1 year of age and under and to determine if concurrent feeding therapy (FT) affects outcome.Study DesignRetrospective case series.SettingTertiary pediatric hospital.MethodsRetrospective review of patients 13 months of age and younger with dysphagia treated by IAIA over a 4‐year period. The efficacy of IAIA was determined by comparing perioperative videofluoroscopic swallow studies (VFSS) and Dysphagia Outcome and Severity Scale (DOSS) scores. Complication rates and utilization of concomitant FT were determined by evaluating postoperative admission and follow‐up records.ResultsSixty‐five patients met inclusion criteria (median age 8 months, interquartile range [IQR]: 7‐11). Sixty‐seven percent of patients improved on postoperative VFSS scores (median improvement in aspiration of 2 thickness levels, IQR 0‐3, P < .0001), and 56% improved in DOSS scores (median increase of 1, IQR: 0‐1.5, P < .0001). Ninety‐two percent of patients were discharged home on the day of surgery. The 30‐day relevant readmission rate was 5%. No patients had intraoperative complications or severe complications at follow‐up. No statistical difference in aspiration or DOSS was noted in the concomitant FT cohort due to a lack of sample size.ConclusionThis study demonstrates that IAIA in children under 13 months old shows comparable rates of success and complications to older patients reported in the literature. No patients had long‐term complications and most were discharged home on the day of surgery. More studies are needed to determine the effect of concomitant FT on IAIA.